Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India. It was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries. Read More
The Drug Controller General of India (DCGI) on Friday granted the approval to the Serum Institute of India (SII) for the initial manufacture of the Russian COVID-19 vaccine Sputnik V for testing, examination, and analysis purposes with certain condit ...
Indian vaccine manufacturing company Serum Institute of India (SII) has sought permission from the Drug Controller General of India (DCGI) for the production of the Russian vaccine Sputnik V in India. ...
Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the Serum Institute of India (SII) has also sought protection against liabilities, sources said on Thursday. ...
Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the fourth quarter and Financial Year ended March 31, 2021. ...
TVS Motor Company registered sales of 166,889 units in May 2021 as against sales of 58,906 units in the month of May 2020. Domestic sales in May 2021 is lower due to lockdowns in many states, but retails continue to be ahead of despatch. We have redu ...
A man in Uttar Pradesh's Lucknow has filed a complaint against Serum Institute of India (SII) CEO Adar Poonawala and Dr. Balram Bhargava, head of the Indian Council of Medical Research (ICMR) after he alleged that no antibodies were formed in his bod ...
The Government of India targets to procure 20 to 25 crore COVID-19 vaccine doses by July-end and 30 crore doses in August-September, informed government sources on Sunday. ...
